F
emale sex is associated with two thirds of the cases of drug-induced polymorphic ventricular tachycardia (PVTs), such as Torsades de Pointes (TdP), which reflects how sex differences may impair women's health. 1 Clinical and experimental studies show that female sex is associated with a greater drug-induced QT prolongation, which facilitates the emergence of TdP. 2, 3 Part of this difference has been ascribed to sex-specific regulation of ionic channel expression by sex steroids. However, a detailed characterization of sex-related alterations of channel expression remains difficult because of spatial heterogeneities in ion channels resulting in dispersions of action potential durations (APDs) and repolarization across the ventricles. 4 -6 Studies have explored the effects of androgen and estrogen replacement in oophorectomized animals and shed new light on how they influence the QT interval. 7, 8 Others have investigated the effects of sex on arrhythmia vulnerability, mostly in large animals like the rabbit. 9 Mice have become important models for cardiovascular diseases, because they represent the principal mammalian species for the production of molecularly engineered transgenic animals. Surface ECG measurements and in vivo cardiac electrophysiology have been successfully performed in mice, 10, 11 but fewer studies have investigated the electrophysiology of isolated mouse hearts. 12 Larger animals have been used successfully to study sex difference in QT interval, 7, 13 drug-induced QT lengthening, 2, 14 and arrhythmia. 9 Sex was shown to influence the QT adaptation to heart rate 11 in mice, but difficulties in measuring APDs or QT dispersion or eliciting arrhythmia have led to the notion that mice are of limited use in this area.
The present report reveals sex differences in perfused spontaneously beating mouse hearts by exposing the hearts to halothane while recording surface electrograms and optical maps of electrical activity elucidate the nature of halothaneinduced arrhythmias.
Methods

Animal Preparations
Sex differences in halothane-induced arrhythmias were studied in mouse hearts perfused in a Langendorff apparatus adapted for ECG or optical mapping. 7, 12 Briefly, mice (Charles River Laboratories, Wilmington, Mass) were anesthetized with sodium pentobarbital (35 mg/kg IP) plus heparin (400 UI/kg). The heart was removed via a midsternal thoracotomy, cannulated at the aorta, and retrogradely perfused at constant flow rate (2.3 mL/min) with Tyrode's solution containing (in mmol/L) NaCl 112, KCl 5, NaHCO 3 25, KH 2 PO 4 1, MgSO 4 1.2, CaCl 2 1.8, and glucose 50, gassed with 95% O 2 and 5% CO 2 at pH 7.38 and 37°C. Pilot experiments (nϭ5) were performed to determine the stability of the model and showed no signs of rundown for Ͼ3 hours with respect to heart rate, ECG, and AP characteristics. ECG studies consisted of 12-week-old male and female OF1 mice (nϭ54) weighing 23 to 32 g.
Optical Apparatus
In parallel experiments, hearts were stained with the voltagesensitive dye di-4-ANEPPS (10 L of 2 mmol/L in DMSO), as previously described. 12 Light from a halogen lamp was collimated, passed through an interference filter (520Ϯ30 nm), and focused on the left epicardium by epi-illumination. Fluorescence was collected with a camera lens passed through a long-pass filter (Ͼ630 nm), and an image of the heart was focused on a 16ϫ16-element photodiode array to simultaneously monitor APs from 256 diodes. Each diode (0.9ϫ0.9 mm 2 , 0.11 mm dead space) recorded APs from hundreds of cells (330ϫ330 m 2 area and a depth of Ϸ70 m). The photocurrent from each diode was passed through an I/V converter (3-M⍀ feedback resistor), amplified, digitized, and stored in computer memory. The perfused hearts were mounted in a chamber designed to abate movement artifacts without the use of chemical uncouplers, which modify the mouse AP. 12 
Northern Blot Analysis
Ventricle RNAs were isolated from 3-week-old and 2-month-old OF1 male and female littermate mouse hearts. Poly(A) ϩ RNA (2 g) were separated by electrophoresis on 1% agarose gel and transferred onto nylon membranes (Hybond N, Amersham). Blots were probed with 32 P-labeled specific cDNA fragments of the different cardiacdelayed rectifier K ϩ channel subunits, including KCNQ1, KCNE1, MERG, and Kv1.5, as well as gap-junction subunits connexins 40 and 43 and the 2P channel TREK1 and TASK1 in Express Hyb solution (Clontech) at 60°C for 16 hours, washed stepwise to a final stringency of 0.2 SSC, 0.3% SDS at 60°C, and exposed to a Fuji Bas-1500 imager for radioactivity quantification. Variations in loading were corrected by ␤-actin probing for internal quantification. Each channel signal was divided by the corresponding ␤-actin signal, yielding a ratio that allowed comparison according to sex.
Electrogram Recordings
Signals were recorded with 4 Ag ϩ -AgCl electrodes from unpaced hearts, which flanked the epicardium in a simulated Einthoven configuration. Electrodes were connected to an adjustable band-pass differential amplifier (ORTEC Inc). ECG channels were amplified and filtered (1 to 2 kHz), stored, and analyzed with the use of pCLAMP (Axon Instruments). The PR interval was measured from the beginning of the P wave to the beginning of the R wave and the QT from the beginning of the Q (or the base of the R wave if not possible) to the end of the T wave, defined as the point at which the voltage returns to the isoelectric baseline. For each heart, a set of 3 consecutive RR-QT interval pairs was obtained from ECG recordings.
This investigation conformed to the guidelines of the Universities of Nice and Pittsburgh and to the Guide for Care and Use of Laboratory Animals (NIH publication No. 85-23, revised 1996).
Halothane Challenge to the Isolated Heart
A Tyrode solution containing 1.75 mmol/L halothane was prepared by diluting Tyrode saturated with 17.5 mmol/L Halothane (Laboratoires) and verified by gas chromatography. A 200-L bolus of 17.5 mmol/L halothane was injected in the 1.8-mL reservoir of Tyrode that serves as a compliance chamber. Continuous perfusion with fresh Tyrode washed out the halothane such that the bolus exposed the heart to a maximum concentration of 1.75 mmol/L halothane that decreased rapidly.
Pilot measurements monitored the occurrence of arrhythmia after a 200-L bolus of halothane; if no arrhythmia occurred, a 300-L bolus and then a 400-L bolus were injected after a 5-minute delay. The bolus of 200 L was chosen because it provoked a ventricular arrhythmia in 5 out of 5 female hearts. In other experiments, an arrhythmia was induced and then propranolol (1 mol/L) was perfused for 10 minutes before repeating the halothane challenge.
Analysis of Optical Data
Simultaneously recorded optical APs were used to determine the spatial heterogeneities of APDs, activation, repolarization patterns, and refractory periods. The activation time point at each diode was taken as the maximum first derivative of the fluorescence upstroke (dF/dt max ), and APD 75 was calculated from the activation minus the repolarization time point (ie, the time when the downstroke recovers 75% to baseline). 12, 15 Hearts were under sinus rhythm or paced with electrodes on the right or left ventricles at the apex or base of the free wall. Mean APD 75 (meanϮSD) was averaged from 9 diodes on the center of the left ventricle and compared for statistical significance between male and female hearts (CLϭ200 ms). Refractory periods were measured by pacing the heart (S 1 to S 1 ϭ200 ms) for 10 beats and then applying a premature impulse (S 2 ) at decreasing S 1 to S 2 intervals from 200 to 100 ms in 5-ms steps, from 100 to 50 ms in 2-ms steps, and then from 50 ms until refractory period in 1-ms steps. 12 Isochronal maps of activation were generated from local activation time points and conduction velocities from the sum of local velocity vectors. 12, 15 APs with S/N ratios Ͻ10/1 or excessive movement artifact were not included in the analysis. Isochronal maps of activation were generated with the Delaunay's triangulation algorithm. 12 Fast Fourier Transforms (FFTs) were calculated to characterize the frequency distribution and spatial organization of VT.
Statistical Analysis
Analysis of ECG waveforms was reported as meanϮSEM. Global descriptive statistics were performed. Statistical analysis according to sex included the proportion of drug-induced arrhythmia that lasted Ն90 seconds (median value of the sample) (analyzed with Fisher's exact test) and the duration of the anesthetic-induced arrhythmia (analyzed with 1-way ANOVA). Because the variability of the data increased with the duration of the arrhythmia and in some hearts an occasional zero value arose (absence of arrhythmia), a logarithmic transformation of the variable was performed 16 according to the formula yϭlog(1ϩx), where x is the total duration of the anestheticinduced ventricular arrhythmia (in seconds). Continuous variables, such as APD 75 , RR, QT, and PR interval values and their increase from baseline, were analyzed with 1-way ANOVA, Student's t test, or Mann-Whitney-Wilcoxon rank-sum test when applicable (all tests performed with Statview 4.5 and SuperAnova 1.11, Abacus Corp). A value of PϽ0.05 was considered statistically significant.
Results
Sex Differences in ECG Waveform
ECG recordings of Langendorff-perfused hearts began 10 minutes after the start of each experiment. The excellent stability of ECG signals made it possible to reliably measure the P, PR, and QT intervals in a total of 54 hearts. As illustrated in Figure 1 , isolated hearts in sinus rhythm had the following mean values (in ms): RR, 193Ϯ25; P-wave duration, 21Ϯ1; PR, 47Ϯ1; and QRS, 15Ϯ0.5 (nϭ54). The average QT interval was 101Ϯ3 ms, yielding a corrected QT (Fridericia) of 175Ϯ4 ms ( Figure 1A) . Females tended to have a slower heart rate than males and a longer QT and QTc, but none of those differences were statistically significant (see Table 1 ).
Effects of Halothane
Halothane produced within 1 minute (39Ϯ2 seconds) a statistically significant prolongation of RR, PR, and QRS intervals ( Figure 1B, Table 2 ). This was rapidly followed by complex ventricular arrhythmia resembling TdP ( Figure 1C ) in all but 5 hearts (nϭ49 of 54). When measurable, the average CL during VT was 57Ϯ2 ms (nϭ44 hearts). The mean duration of these arrhythmias (median, 90 seconds) was approximately equal to the time taken for the bolus of halothane to pass and wash out through the coronary circulation. After washout, arrhythmias ceased and the heart returned to sinus rhythm ( Figure 1D ) at a slower rate (RRϭ232Ϯ8 ms) and with longer PR intervals (75Ϯ3 ms, PϽ0.0001), which gradually returned to control in Ϸ3 minutes. Table 2 summarizes the changes in electrophysiological parameters caused by halothane.
Sex and Arrhythmias
Even though the time elapsed from the bolus injection to the onset of arrhythmia did not differ between sexes (male, 38Ϯ3 seconds versus female, 40Ϯ2 seconds, PϽ0.7), the occurrence and the duration of PVTs did vary with sex ( Figure 2A ). Male hearts were more resistant (25%) to halothane-induced PVTs than were their female counterparts (0%, PϽ0.05), and the durations of arrhythmias markedly differed according to sex ( Figure 2B ). Male hearts (17%) had PVTs lasting longer than the median value of 90 seconds, whereas most female hearts (55%) had arrhythmias exceeding it (PϽ0.05). The duration of PVTs was longer in female (378Ϯ44 seconds) than in male (27Ϯ10 seconds) hearts (nϭ49, PϽ0.05) (Figures 2, B and C) . The cycle length of arrhythmias tended to be longer in females (60Ϯ3 ms) than in males (51Ϯ5 ms), but the difference fell within experimental error (Pϭ0.07). Propranolol (1 mol/L) was remarkably effective at protecting the hearts from halothane-induced arrhythmias in both sexes (nϭ5).
Sex Differences in APDs and Refractory Periods
Optical recordings detected a tendency for shorter APD 75 in male compared with female hearts, although the difference was not statistically significant. The mean spontaneous CL Halothane induced a prolongation of the PR interval (80 ms) followed by premature ventricular beats and brief pauses preceding the onset of arrhythmia. C, PVT are more prolonged (7 minutes) in female hearts. D, On washout of halothane, arrhythmia spontaneously disappears. In most male hearts, PVT end within 1 minute (PϽ0.01, nϭ49 hearts). P, QRS, and T waves are labeled accordingly. . APD 75 indicates optical APDs measured at 75% recovery to baseline, at 200 ms CL, averaged over 9 diodes per heart (nϭ5 hearts) in ms; ⌰ mean , mean conduction velocity in m/s calculated from the average conduction velocity in 5 hearts paced at 200 ms CL; and ARP, gradients of refractoriness (difference between apex and base), nϭ5 hearts, in ms.
Statistically significant values between male and female hearts are found for the incidence (*PϽ0.7) and duration ( †PϽ0.05) of PVT. was 225Ϯ12 ms with an APD 75 ϭ23.11Ϯ4.2 ms (nϭ5 male and 5 female, 9 diodes/heart) in the absence of halothane ( Figure 3A) . When paced at a CL of 200 ms, ventricular APD 75 of male and female hearts (nϭ5 hearts each) were not statistically different. Refractory periods were heterogeneous across the epicardium, being short at the apex and progressively longer toward the base. The gradient of refractoriness (difference between apex and base) had a tendency of being greater in female than in male hearts (10.8Ϯ2.5 versus 9.6Ϯ0.89 ms), but without statistical significance (Table 1) . Halothane (200-L bolus) elicited a tachycardia (CLϭ65 ms) and a shortening of APD 75 to 17.61Ϯ1.6 ms (nϭ5) ( Figure  3C ). An activation pattern of an arrhythmic beat ( Figure 3D) shows that activation propagated from right to left (bright to dark) in 5 to 6 ms. The stability of activation patterns and ECG from the opposite side of the heart indicated that the arrhythmia was a reentrant monomorphic circuit around the perimeter of the heart. 12 The nature of arrhythmias elicited by halothane was investigated by mapping optical voltage oscillations during VTs. Halothane elicited more severe arrhythmias in female than male hearts, resulting in complete arrest of female hearts but brief MVTs (nϭ4 of 6) or PVTs (nϭ2 of 6) in male hearts. MVTs (960 beats/min) had a dominant frequency (mean 13.9Ϯ3.3 ms Hz, nϭ4) in their FFT spectra ( Figure  3E ) and Poincaré maps of interactivation intervals with stable CL (65.0Ϯ3.24, nϭ9 beats), with all points falling in a tight cluster indicative of stable reentry ( Figure 3F ). Hearts in halothane-induced PVTs exhibited regions with MVTs (Figure 4A ) with a dominant frequency ( Figure 4B ) and regions with more complex voltage oscillations ( Figure 4C ) and FFT spectra (nϭ2 of 6) ( Figure 4D ). These results indicate that on the anterior surface of the heart, there are regions with out-of-phase monomorphic VTs and other regions with polymorphic VTs.
Northern Blots
As in previous work, the level of KCNE1 mRNA was high in 3-week-old mouse hearts and decreased with age, reaching a low but detectable level at 12 weeks. 11 The signal was sex-balanced in 3-week-old mice (ratio of male to female, 1.1) but more pronounced in adult female mice by 2-to 3-fold. The amount of messenger RNA for the other delayed rectifier subunits, including KCNQ1, Kv1.5 (encoding I Ksus ), MERG (the mouse counterpart of HERG), and connexin 40 and 43, TREK1, and TASK1 were not influenced by sex.
Discussion
The manipulation of genes in the mouse has yielded important animal models to study how specific gene products modify the phenotype of complex physiological systems. Transgenic and gene-targeted mice have been developed to study cardiac arrhythmias; some are engineered to model human arrhythmias or human diseases in which arrhythmias occur. 17 Other models are made to manipulate steroid hormone receptors to investigate how sex differences influence the cardiac phenotype. 18 Once a molecularly engineered mouse is made, its phenotype must be characterized and correlated to an aspect of human physiology or pathophysiology. There are striking differences between mice and men with respect to heart rate, ventricular AP shape and durations, ionic currents involved in cardiac repolarization, and size of hearts. 17 Despite these differences, there are striking parallels in mice and larger mammals with regard to gradients of repolarization and refractoriness, the spatial distribution of ionic channels, and the induction of reentry, although different ion channels are involved. 12 
Sex Differences Exposed by Halothane
Halothane has long been known to exert variable effects on cardiac rhythm 19 and was shown to decrease heart rate and increase PR and QT intervals in dogs. 20 Several cardiac channel currents are altered by halothane, namely a ubiquitous blockade of I Na , I CaL , 21 potassium channels, including I K 22,23 and derangements of gap junctions that could contribute to arrhythmia. 24 In mammalian species, gap junctions are formed by isoforms of connexins where connexin 43 is expressed throughout the heart, connexin 40 in atrial muscles, and connexin 45 in the conduction system. 25 Connexin 43 has been implicated in the pathogenesis of ventricular arrhythmia in mice. 24 It is unlikely that sex differences in connexin explain these PVTs because no differences in connexin mRNAs were observed and normal P waves were recorded throughout such arrhythmia. Similarly, an eventual role of I Kr , the rapid component of the delayed rectifier I Kϩ , is not obvious, because specific I Kr blockers (dofetilide and E4031) do not modify the mouse ECG. 2P channels (TREK 1 and 2 and TASK 1) could be targeted by halothane but would be protective rather than arrhythmogenic because of their tendency to induce cell hyperpolarization. Finally, with the exception of KCNE1 mRNA, which is expressed at lower levels in males (1 of 3) than in females, no other sex differences were seen in Northern blots. The duration of halothane-induced PVTs in male hearts (Ϸ1 minute, maximum 3 minutes) roughly equals the time that halothane In all activation maps, the first site to depolarize is depicted in "light gray" (ie, time tϭ0.0 ms) and subsequent depolarizations in increasingly darker shades; isochronal lines are 1 ms apart. C, APs during MVT. APs recorded from a diode after the addition of halothane. D, Activation map during an arrhythmia after the addition of halothane. E, FFT spectra of an arrhythmia. The FFT spectrum was analyzed over a 1.25 second time interval after the injection of halothane to mouse heart. The power spectrum of voltage oscillations during an arrhythmia displayed a dominant frequency of 15 Hz. F, Poincaré map of inter-activation intervals during an arrhythmia. Plot I nϩ1 versus I n where I n is the inter-activation interval of beat n of VT. The interactivation intervals demonstrated the stability of the VT since the VT cycle length fell in the narrow range of 64 to 68 ms. lasts in the coronary circulation. This is markedly different in female hearts where arrhythmias last far longer (ie, 14 to 44 minutes), emphasizing the importance of this observation, even if the mechanism of such a difference remains unclear.
Relevant Model of Sex Differences
Several models have been used for evaluating sex differences in QT interval and arrhythmia, including dogs 26 and rabbits. 8 Mice display a sex-dependent QT adaptation to heart rate with a steeper slope in females resulting in a longer QT during bradycardia in female mice. 11 The present study sheds new light on the relevance of mouse hearts as a model of sex differences by revealing sex differences in the occurrence of PVTs in this species. Differences in the expression cardiac ionic channels or their modulation can account for sexdependent PVTs, yet Northern blot experiments do not suggest so, with the exception of KCNE1. 
